Trademark: DAXXIFY
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for DAXXIFY
We do not have any records of a proof of use for DAXXIFY at this moment.
Possible trademark infringements of DAXXIFY
Basic Information about DAXXIFY
- Serial Number
- 88984738
- Filing Date
- 30 Mar 2020
- Registration Number
- 6931535
- Registration Date
- 20 Dec 2022
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of DAXXIFY on the blockchain with WikiTrademarks.io.
- First use of DAXXIFY anywhere
- DAXXIFY was first used on 26 Sep 2022 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns DAXXIFY?
1. Revance Therapeutics, Inc. Newark CA
2. Revance Therapeutics, Inc. Newark CA
3. Revance Therapeutics, Inc Newark CA
Correspondent
- Maren C. Perry
- KING & SPALDING LLP
- 1185 AVENUE OF THE AMERICAS
- NEW YORK, NY 10036
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io